Member Info for lukeregan180

Expecting more

There you go, Tobin.

He last bought on 16 December 2022. Probably largely been in a closed period since then. Let’s see if he has a nibble this week - I bet he will.

Some rather large prints showing.. TR1?

If we get some significant director buys here this could bounce hard.

We know they aren’t shy in backing the company (buys in July at multiples of the current share price).

1. Probably goes down a bit and then ends up about level / maybe a bit up within a few days.
2. Goes down by quite a lot
3. Goes up by quite a lot

It hasn’t been approved as Orphan yet it is awaiting approval. However obviously the fact that Avacta have submitted it for approval would suggest that they are happy with the data etc and think it works.

Next RNS will be the next Miton TR1

Joined up and had a read. Nothing surprising on there really.

Blackrock TR1 perhaps.

Can someone post the notes here please

CEO confirms closed period the last month - hence the Tobin non buying (last buying RNS 14/06). Would think he’d start buying again soon then.

For balance - Miton also today declared they had gone from 9.9% to 3.3% in Tissue Regenix Group. Also a branch of Miton went from 4.6% to 3.9% in Kinovo.

That’s not me taking away from the woeful lack of progress at Quadrise though.

Not really. Would be be surprised if anything before September though.

Mr Tobin had been buying constantly at prices significantly higher than this until a couple of weeks ago. Hopefully suggestive of him not being allowed to buy at the moment - surely he would be filling his boots at these levels otherwise ?

Where are the significant shareholders listed on the THG website?

Definitely wasn’t there Thursday / Friday - website now states that Meduflow detects Omicron.

https://www.medusa19.com/en/meduflow-rapid-antigen-test/

Someone has been loading up big time here this afternoon. So many large rounded buys

Think we’re close

Yes